Citigroup, West Pharmaceutical Services and WST
West Pharmaceutical Services (NYSE:WST) Earns Buy Rating from Analysts at Citigroup
Stock analysts at Citigroup started coverage on shares of West Pharmaceutical Services (NYSE:WST – Get Free Report) in a report released on Wednesday, MarketBeat reports. The brokerage set a “buy” rating and a $400.
West Pharmaceutical Services (WST) stock is down 16% due to deteriorating fundamentals, with emphasis on future growth ...
1776 , A Christmas Story , Million Dollar Quartet , More in Walnut Street Theatre's 2025-2026 Season
The upcoming season is the Philadelphia theatre's 217th. Walnut Street Theatre (WST) has revealed the lineup of productions ...
Check the time stamp on this data. Updated AI-Generated Signals for West Pharmaceutical Services Inc. (WST) available here: ...
Citi initiated coverage of West Pharmaceutical (WST) with a Buy rating and $400 price target West is a provider of packaging and injectable ...
Hosted on MSN6d
LH vs. WST: Which Stock Is the Better Value Option?Investors interested in Medical - Dental Supplies stocks are likely familiar with Labcorp (LH) and West Pharmaceutical Services (WST). But which of these two companies is the best option for those ...
Below is Validea's guru fundamental report for WEST PHARMACEUTICAL SERVICES INC. (WST). Of the 22 guru strategies we follow, WST rates highest using our P/B Growth Investor model based on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback